- Info
- Significant Ownership
Significant Ownership of Teoxane SA
- Signature - Title
- /s/ Patrice Calvayrac - Patrice Calvayrac/ Chief Financial Officer
- Location
- Geneva, Switzerland
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Teoxane SA.
Follow Filing Activity
Follow Teoxane SA and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Teoxane SA
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| RVNC | Revance Therapeutics, Inc. | Common Stock, par value $0.001 per share | 6.2% | $32,335,404 | 6,550,800 | 0% | Teoxane SA | 30 Jan 2025 |
Schedules 13D/G Reported by Teoxane SA:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.